ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narula, J.
Right arrow Articles by Baliga, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narula, J.
Right arrow Articles by Baliga, R.
Related Collections
Right arrow Cerebral protection

Ann Thorac Surg 2001;72:1454-1456
© 2001 The Society of Thoracic Surgeons


Editorial

What’s in a name? Would that which we call death by any other name be less tragic?

Jagat Narula, MD, PhD*a, Ragavendra Baliga, MDb

a MCP-Hahnemann University Medical School, Philadelphia, Pennsylvania, USA
b University of Michigan Health Systems, Ann Arbor, Michigan, USA

* Address reprint requests to Dr Narula, Hahnemann University Hospital, Broad & Vine, MS115-NT742, Philadelphia, PA 19102-1192, USA
e-mail: jagat.narula@drexel.edu

Open-heart surgery, particularly coronary artery bypass grafting (CABG) for coronary artery disease, is one of the great success stories in modern cardiovascular therapeutics, with more than 500,000 bypass procedures performed in the United States each year [1]. It not only improves survival but also relieves angina and improves exercise tolerance. This success story, however, has its trade-offs, including injury to the myocardium and central nervous system during circulatory arrest or low-flow bypass [2, 3]. Surgeons and researchers have grappled with different techniques to minimize neurologic dysfunction after open-heart surgery. The incidence of adverse cerebral outcomes after CABG ranges from 0.4% to approximately 80%. Perioperative cerebral injury has been divided into major deficits, which include focal neurologic deficits, coma, delirium and stupor; or relatively minor deficits, which include deterioration in short-term and long-term cognitive functions such as intellectual function and memory [1]. These cognitive changes may be subtle and may include problems with following directions, mental arithmetic, and planning complex actions [4]. In addition, family members and colleagues may observe that the patient is more prone to be short-tempered, is less able to withstand frustration, and has wider mood swings. The deterioration in cognitive function may demonstrate a biphasic temporal pattern with an immediate postoperative decline and then a late decline on long-term follow-up [5]. The pathogenesis of neurologic deficits after CABG has been ascribed to hypoxia, recurrent emboli, hemorrhage and metabolic abnormalities. The cellular and molecular mechanisms that result in neurologic deficits, particularly the decline in late cognitive function, continue to be defined. In a very elegant article in . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Circ. Res.Home page
Y. Chandrashekhar and J. Narula
Death Hath a Thousand Doors To Let Out Life...
Circ. Res., April 18, 2003; 92(7): 710 - 714.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.